Bristol-Myers Squibb
BMY
2,214 hedge funds and large institutions have $100B invested in Bristol-Myers Squibb in 2020 Q3 according to their latest regulatory filings, with 135 funds opening new positions, 889 increasing their positions, 913 reducing their positions, and 89 closing their positions.
52% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 89
1% more funds holding
Funds holding: 2,185 → 2,214 (+29)
0.01% less ownership
Funds ownership: 73.96% → 73.95% (-0.01%)
3% less repeat investments, than reductions
Existing positions increased: 889 | Existing positions reduced: 913
4% less capital inflows, than outflows
Capital inflows: $5.58B | Capital outflows: $5.82B
6% less call options, than puts
Call options by funds: $1.39B | Put options by funds: $1.48B
15% less funds holding in top 10
Funds holding in top 10: 110 → 93 (-17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Berkshire Hathaway
Omaha,
Nebraska
|
+$1.8B |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$207M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$192M |
| 4 |
Janus Henderson Group
London,
|
+$154M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$778M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$582M |
| 3 |
Goldman Sachs
New York
|
-$469M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$230M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$183M |
BMY Hedge Fund Activity: Q3 2020 in Review
2,214 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2020, worth a combined $100B — up 2.3% from $98.2B a quarter earlier.
Buyers outnumbered sellers: 135 funds opened new BMY positions and 89 closed out — a net gain of 46 holders — while 889 added to existing stakes and 913 trimmed.
The largest buyer was Berkshire Hathaway, opening a new position worth an estimated $1.8B. The largest seller was Renaissance Technologies, cutting an estimated $778M.
- 2,214 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2020, up from 2,185 in Q2 2020.
- Funds reported $100B of Bristol-Myers Squibb stock for Q3 2020, up 2.3% quarter-over-quarter.
- 135 funds opened new Bristol-Myers Squibb positions in Q3 2020 and 89 closed out, a net change of +46 holders.
- The largest Bristol-Myers Squibb buyer in Q3 2020 was Berkshire Hathaway, an estimated $1.8B added.
- The largest Bristol-Myers Squibb seller in Q3 2020 was Renaissance Technologies, an estimated $778M sold.
Based on aggregated 13F filings for Q3 2020.